![Gordon F. Beck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon F. Beck
Geen lopende functies
Profiel
Dr. Gordon F.
Beck is Vice President-Business Development at AuraSense Therapeutics LLC.
Dr. Beck was previously employed as a Principal by Gb4bd LLC.
He received his doctorate degree from the University of Aston.
Eerdere bekende functies van Gordon F. Beck
Bedrijven | Functie | Einde |
---|---|---|
Gb4bd LLC | Corporate Officer/Principal | - |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Corporate Officer/Principal | - |
Opleiding van Gordon F. Beck
University of Aston | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Gb4bd LLC |